Guidelines for conducting health economic evaluations have become increasingly standardized, however, they don't address the unique concerns of the pediatric population. The challenges of measuring costs and consequences in children, from neonate to late adolescence, are numerous and complex. With the growing acceptance of economic evidence to guide decisions in health systems facing economic constraints, it is imperative that these challenges be considered so that this population is not left out of evidence-based decisions.
Guidelines for conducting health economic evaluations have become increasingly standardized, however, they don't address the unique concerns of the pediatric population. The challenges of measuring costs and consequences in children, from neonate to late adolescence, are numerous and complex. With the growing acceptance of economic evidence to guide decisions in health systems facing economic constraints, it is imperative that these challenges be considered so that this population is not left out of evidence-based decisions.
Wendy Ungar MSc, PhD is a Senior Scientist in Child Health Evaluative Sciences at the Hospital for Sick Children, Toronto, Canada, an Associate Professor in Health Policy, Management and Evaluation, University of Toronto, and an Adjunct Scientist at the Institute for Clinical Evaluative Sciences, Toronto, Canada. Dr. Ungar is the University of Toronto Program Director for the International Masters in Health Technology Assessment & Management (Ulysses program) and has held a Canadian Institutes of Health Research New Investigator career award. Dr. Ungar leads a program of research in the application of health economic methods to the paediatric population and also investigates the relationship between policies governing access to prescription medicines and health outcomes in children. Dr. Ungar and her research team created and maintain the PEDE database (http://pede.ccb.sickkids.ca/pede/), a popular on-line health technology assessment tool for examining health economic evidence in children.
Inhaltsangabe
* Methods * 1: Wendy J. Ungar and Andreas Gerber: The uniqueness of child health and challenges to measuring costs and consequences * 2: Katherine Bevans and Christopher B. Forrest: The reliability and validity of children's and adolescents' self-reported health * 3: Werner B.F. Brouwer, N. Job A. van Exel and J. Mick Tilford: Incorporating caregiver and family effects in economic evaluations of child health * 4: Lillian Sung, Stavros Petrou and Wendy J. Ungar: Measurement of health utilities in children * 5: Andrew R Willan: The use of value of information methods in the design and evaluation of clinical trials * Applications * 6: Scott D. Grosse: Economic evaluations of newborn screening * 7: Kim Dalziel and Leonie Segal: Economic evaluation in child protection: what are the special challenges? Part 1. Economic evaluation in child protection * Economic evaluation in child protection: what are the special challenges? Part 2. Economic evaluation in child welfare * Economic evaluation in child protection: what are the special challenges? Part 3. Economic evaluation in Fetal Alcohol Spectrum Disorder * 8: Sarah Byford: Obstacles to the economic evaluation of specialist child and adolescent mental health services * 9: J. Mick Tilford and Ali I. Raja: Is more aggressive treatment of pediatric traumatic brain injury worth it? * 10: Jonathan D. Campbell and Sean D. Sullivan: Economic evaluations in the management of paediatric asthma * 11: Damian G Walker, Philippe Beutels and Raymond Hutubessy: Economic evaluation of childhood vaccines * 12: Donald S. Shepard and Jose A. Suaya: Economic evaluation of dengue prevention * Using Evidence for Decision-Making * 13: Tessa Tan-Torres Edejer, Moses Aikins, Robert Black, Lara Wolfson, Raymond Hutubessy and David B. Evans: Economic evaluations of interventions for children in the developing world: the WHO-CHOICE approach * 14: Gillian Currie, Sarah Curtis and Terry Klassen: Evidence-based decision-making in child health: the role of clinical research and economic evaluation * 15: Stavros Petrou: Should health gains by children be given the same value as health gains by adults in an economic evaluation framework? * 16: Vania Costa and Wendy J. Ungar: Health-technology assessment in child health
* Methods * 1: Wendy J. Ungar and Andreas Gerber: The uniqueness of child health and challenges to measuring costs and consequences * 2: Katherine Bevans and Christopher B. Forrest: The reliability and validity of children's and adolescents' self-reported health * 3: Werner B.F. Brouwer, N. Job A. van Exel and J. Mick Tilford: Incorporating caregiver and family effects in economic evaluations of child health * 4: Lillian Sung, Stavros Petrou and Wendy J. Ungar: Measurement of health utilities in children * 5: Andrew R Willan: The use of value of information methods in the design and evaluation of clinical trials * Applications * 6: Scott D. Grosse: Economic evaluations of newborn screening * 7: Kim Dalziel and Leonie Segal: Economic evaluation in child protection: what are the special challenges? Part 1. Economic evaluation in child protection * Economic evaluation in child protection: what are the special challenges? Part 2. Economic evaluation in child welfare * Economic evaluation in child protection: what are the special challenges? Part 3. Economic evaluation in Fetal Alcohol Spectrum Disorder * 8: Sarah Byford: Obstacles to the economic evaluation of specialist child and adolescent mental health services * 9: J. Mick Tilford and Ali I. Raja: Is more aggressive treatment of pediatric traumatic brain injury worth it? * 10: Jonathan D. Campbell and Sean D. Sullivan: Economic evaluations in the management of paediatric asthma * 11: Damian G Walker, Philippe Beutels and Raymond Hutubessy: Economic evaluation of childhood vaccines * 12: Donald S. Shepard and Jose A. Suaya: Economic evaluation of dengue prevention * Using Evidence for Decision-Making * 13: Tessa Tan-Torres Edejer, Moses Aikins, Robert Black, Lara Wolfson, Raymond Hutubessy and David B. Evans: Economic evaluations of interventions for children in the developing world: the WHO-CHOICE approach * 14: Gillian Currie, Sarah Curtis and Terry Klassen: Evidence-based decision-making in child health: the role of clinical research and economic evaluation * 15: Stavros Petrou: Should health gains by children be given the same value as health gains by adults in an economic evaluation framework? * 16: Vania Costa and Wendy J. Ungar: Health-technology assessment in child health
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
